Approach to diagnosing and managing granulomatous-lymphocytic interstitial lung disease
Jessica Galant-Swafford, Jason Catanzaro, Rosane Duarte Achcar, Carlyne D. Cool, Tilman Koelsch, Tami J. Bang, David A. Lynch, Rafeul Alam, Rohit Katial, Evans R. Fernández Pérez
Abstract
Granulomatous-lymphocytic interstitial lung disease (GLILD) is a lymphoproliferative and granulomatous pulmonary manifestation of primary immune deficiency diseases, notably common variable immunodeficiency (CVID), and is an important contributor of excess morbidity. As with all forms of ILD, the significance of utilizing a multidisciplinary team discussion to enhance diagnostic and treatment confidence of GLILD cannot be overstated. In this review, key clinical, radiological, and pathological features are integrated into a diagnostic algorithm to facilitate a consensus diagnosis. As the evidence for diagnosing and managing patients with GLILD is limited, the viewpoints discussed here are not meant to resolve current controversies. Instead, this review aims to provide a practical framework for diagnosing and evaluating suspected cases and emphasizes the importance of a multidisciplinary approach when caring for GLILD patients.